Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniele Tota
Pulmonary Arterial Hypertension in ALK Receptor Tyrosine Kinase–Positive Lung Cancer Patient: Adverse Event or Disease Spread?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension
Advances in Pulmonary Hypertension
P1.02-05 ALK Positive Lung Cancer: Patient Engagement and Partnership
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Development of Anaplastic Lymphoma Kinase (ALK) Inhibitors and Molecular Diagnosis in ALK Rearrangement-Positive Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
P1.15-16 ALKConnect: An Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Patient Insights Network
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Tyrosine Kinase Inhibitors in Lung Cancer
Hematology/Oncology Clinics of North America
Oncology
Hematology
Pulmonary Arterial Hypertension in Congenital Heart Disease
Continuing Cardiology Education
ALK, ROS1 and EGFR Next-Generation Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer
Oncology in Clinical Practice
Oncology
Other Causes of Pulmonary Arterial Hypertension: Pulmonary Veno-Occlusive Disease, Pulmonary Capillary Hemangiomatosis, Porto-Pulmonary Hypertension, HIV- Associated Pulmonary Arterial Hypertension
Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
Non-Tuberculous Mycobacterial Lung Disease (NT MLD ) in Patients With Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension
Pneumonologia i Alergologia Polska
